Home › Angioedema
Angioedema clinical trials recruiting in the U.S.
6 studies for Angioedema are recruiting participants at sites across the United States.
Recently updated studies
Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07266805Angioedema Biomarker Research Study
RecruitingObservational studyHealthy volunteers welcome
Ages 12 to 75 · All sexes · Updated Aug 24, 2026 · NCT06210698A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)
RecruitingObservational study
Ages 12 and older · All sexes · Updated Jun 3, 2026 · NCT07001280Allergy and Immunology Natural History Study
RecruitingObservational studyHealthy volunteers welcome
Up to age 99 · All sexes · Updated Feb 4, 2026 · NCT05584488Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Jul 2, 2025 · NCT07046806Lanadelumab in Long-term Prophylaxis of Acquired Angioedema
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Feb 25, 2025 · NCT06818474From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.